Clinical analysis of stages of HBV infection in 100 cases of lymphoma

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 2, 2013, Pages 959-962

  Tang, Yang ^a   Sun, Li Guang ^a   Liu, Chun Shui ^a   Li, Yu Ying ^a   Jin, Chun Hui ^a   Li, Dan ^a   Bai, Ou ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Hepatitis B virus; Lymphoma; Serum markers

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; B CELL LYMPHOMA; BLOOD; CASE CONTROL STUDY; CHINA; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HODGKIN DISEASE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; QUESTIONNAIRE; T CELL LYMPHOMA; VIROLOGY;

ADULT; CASE-CONTROL STUDIES; CHINA; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HODGKIN DISEASE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; QUESTIONNAIRES; TUMOR MARKERS, BIOLOGICAL;

EID: 84877653898     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.2.959     Document Type: Article

References (26)

1. Alexander DD, Mink PJ, Adami HO, et al (2007). The non-Hodgkin lymphomas: a reviewof the epidemiologic literature. Int J Cancer, 120, 1-39.
2. Altman BJ, Dang CV (2012). Normal and cancer cell metabolism: lymphocytes and lymphoma. FEBS J, 279, 2598-609.
3. Becker N, Schnitzler P, Boffetta P, et al (2012). Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol, 138, 1993-2001.
4. Cucuianu A, Patiu M, Duma M, et al (1999). Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol, 110, 497-8.
5. Elaine SJ (2008). World Health Organization Classification of Tumors and the Diagnostic Criteria. ISBN-13: 9789283224112.
6. Eric AE, Eo RC, Sun HJ, et al (2010). Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol, 11, 827-34.
7. Fabrizio M, Enea S, Alfonso M, et al (2012) .The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review. Am J Blood Res, 2, 18-28.
8. Jay HH (2009). Reactivation of Hepatitis B. Hepatology, 49, 156-65.
9. Kang J, Cho JH, Suh CW, et al (2011). High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol, 90, 159-64.
10. Kathryn T, Michelle SM, Amick AC et al (2010) . Epstein-Barr Virus in Burkitt's Lymphoma: a role for Latent Membrane Protein 2A. Cell Cycle, 9, 901-8.
11. Kim YM, Jeong SH, Kim JW, et al (2011). Chronic hepatitis B, non-Hodgkin's lymphoma,and effect of prophylactic antiviral therapy. J Clin Virol, 51, 237-41.
12. Li J, Han YP, Ke J, et al (2011). Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer(NK) cells, and natural killer T(NKT) cells in patients with acute hepatitis B infection. Virol J, 8, 199.
13. Mele A, Pulsoni A, Bianco E, et al (2003) . Hepatitis C virus and B cell non- Hodgkin's lymphomas: an Italian multicenter case control study. Blood, 102, 996-9. .
14. Michalek RD , Rathmell JC (2010). The metabolic life and times of a T-cell. Immunol Rev, 236, 190-202.
15. Chen MH, Hsiao LT, Chiou TJ, et al (2008). High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin's lymphoma. Ann Hematol, 87, 475-80.
16. Nath A, Agarwal R, Malhotra P, et al (2010). Prevalence of hepatitis B virus infection in non-Hodgkin's lymphoma. A systematic review and meta-analysis. Intern Med J, 125, 1723-32.
17. Park SC, Jeong SH, Kim J, et al (2008). High prevalence of hepatitis B virus infection in patients with B-cell non-Hodgkin lymphoma in Korea. J Med Virol, 80, 960-6.
18. Quinn ER, Chan CH, Hadlock KG, et al (2001). The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood, 98, 3745-9.
19. Rehermann B, Nascimbeni M (2005) . Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol, 5, 215-29.
20. Shankland KR, Armitage JO, Hancock BW et al (2012). Non-Hodgkin lymphoma. Lancet, 380, 848-57.
21. Thorley-Lawson DA, Allday MJ (2009). The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol, 2008, 913-24.
22. Tiollais P, Pourcel C, Dejean A (1985). The hepatitis B virus. Nature, 17, 489-95.
23. Ulcickas Yood M, Quesenberry CP (2007). Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology, 46, 107-12.
24. Wang F, Xu RH, Han B, et al (2007). High incidence of hepatitis B virus infection in B-cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer, 109, 1360-4.
25. Wang XQ (2006). Cytogenetic study on 155 cases of non-Hodgkin's lymphoma. Zhonghua Xue Ye Xue Za Zhi, 7, 656-60.
26. Zhu ZZ, Cong WM, Liu SF, et al (2005). A p53 polymorphism modifies the risk of hepatocellular carcinoma among noncarriers but not carriers of chronic hepatitis B virus infection. Cancer Lett, 229, 77-83.